New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 26, 2014
08:21 EDTONVOOrganovo says 3D Liver system distinguished toxic drug in study
Organovo announced that an opinion leader reported results from a collaborative study conducted with Organovo scientists using Organovo’s 3D Human Liver Tissues. Dr. Adrian Roth, Head of Mechanistic Safety for Roche Pharmaceutical Research and Early Development at the Roche Innovation Center Basel, presented results from a collaborative study executed by Organovo scientists. The results of the study showed Organovo’s 3D Liver system was able to distinguish a toxic drug known to cause drug induced liver injury from a close chemical analogue that is known to be non-toxic, the company said. "Further, the toxicity of the toxic compound was detected at physiologically relevant doses, an important observation not previously reported with the same compounds in other model liver systems," it added. Organovo said it continues to be on track to launch its upcoming 3D Human Liver Tissue on its previously announced timelines, before the end of 2014.
News For ONVO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
June 29, 2015
10:09 EDTONVOOn The Fly: Analyst Initiation Summary
Subscribe for More Information
06:56 EDTONVOOrganovo initiated with a Buy at Jefferies
Target $5.
05:41 EDTONVOOrganovo initiated with an Overweight at Piper Jaffray
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use